Magnesium in PDB 2j87: Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design
Enzymatic activity of Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design
All present enzymatic activity of Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design:
2.7.1.21;
Protein crystallography data
The structure of Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design, PDB code: 2j87
was solved by
K.El Omari,
N.Solaroli,
A.Karlsson,
J.Balzarini,
D.K.Stammers,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
30.00 /
3.10
|
Space group
|
P 31
|
Cell size a, b, c (Å), α, β, γ (°)
|
63.331,
63.331,
166.412,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
25.7 /
28.9
|
Other elements in 2j87:
The structure of Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design
(pdb code 2j87). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 4 binding sites of Magnesium where determined in the
Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design, PDB code: 2j87:
Jump to Magnesium binding site number:
1;
2;
3;
4;
Magnesium binding site 1 out
of 4 in 2j87
Go back to
Magnesium Binding Sites List in 2j87
Magnesium binding site 1 out
of 4 in the Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg500
b:15.6
occ:1.00
|
O3B
|
A:TTP300
|
2.1
|
47.9
|
1.0
|
O1A
|
A:TTP300
|
2.4
|
45.1
|
1.0
|
PB
|
A:TTP300
|
2.8
|
50.2
|
1.0
|
O3A
|
A:TTP300
|
2.8
|
48.4
|
1.0
|
O3G
|
A:TTP300
|
2.9
|
47.3
|
1.0
|
PG
|
A:TTP300
|
3.0
|
47.0
|
1.0
|
O2B
|
A:TTP300
|
3.1
|
50.3
|
1.0
|
PA
|
A:TTP300
|
3.2
|
46.4
|
1.0
|
N
|
A:PHE14
|
3.5
|
43.2
|
1.0
|
CB
|
A:MET13
|
3.7
|
43.5
|
1.0
|
O2G
|
A:TTP300
|
3.8
|
46.9
|
1.0
|
O5'
|
A:TTP300
|
3.9
|
46.6
|
1.0
|
CA
|
A:MET13
|
4.1
|
43.4
|
1.0
|
CD1
|
A:PHE14
|
4.2
|
42.9
|
1.0
|
O1G
|
A:TTP300
|
4.3
|
45.7
|
1.0
|
O1B
|
A:TTP300
|
4.3
|
50.4
|
1.0
|
C
|
A:MET13
|
4.3
|
43.4
|
1.0
|
CA
|
A:PHE14
|
4.4
|
43.2
|
1.0
|
CE
|
A:MET13
|
4.5
|
43.0
|
1.0
|
O2A
|
A:TTP300
|
4.5
|
46.1
|
1.0
|
CE1
|
A:PHE14
|
4.6
|
43.1
|
1.0
|
CG
|
A:MET13
|
4.6
|
43.4
|
1.0
|
SD
|
A:MET13
|
4.7
|
43.4
|
1.0
|
CG
|
A:PHE14
|
5.0
|
43.2
|
1.0
|
|
Magnesium binding site 2 out
of 4 in 2j87
Go back to
Magnesium Binding Sites List in 2j87
Magnesium binding site 2 out
of 4 in the Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg500
b:22.2
occ:1.00
|
O1A
|
B:TTP300
|
1.7
|
26.6
|
1.0
|
O3G
|
B:TTP300
|
1.9
|
35.9
|
1.0
|
O2B
|
B:TTP300
|
2.2
|
37.4
|
1.0
|
PA
|
B:TTP300
|
2.8
|
28.2
|
1.0
|
O2A
|
B:TTP300
|
3.0
|
27.4
|
1.0
|
PG
|
B:TTP300
|
3.1
|
35.7
|
1.0
|
PB
|
B:TTP300
|
3.2
|
37.3
|
1.0
|
N
|
B:PHE14
|
3.3
|
43.3
|
1.0
|
CB
|
B:MET13
|
3.5
|
43.4
|
1.0
|
O3B
|
B:TTP300
|
3.5
|
36.2
|
1.0
|
O3A
|
B:TTP300
|
3.6
|
32.4
|
1.0
|
O2G
|
B:TTP300
|
3.7
|
33.9
|
1.0
|
CA
|
B:MET13
|
3.8
|
43.3
|
1.0
|
C
|
B:MET13
|
4.1
|
43.3
|
1.0
|
O5'
|
B:TTP300
|
4.2
|
29.2
|
1.0
|
O1G
|
B:TTP300
|
4.3
|
36.0
|
1.0
|
CA
|
B:PHE14
|
4.3
|
43.3
|
1.0
|
CD1
|
B:PHE14
|
4.3
|
42.9
|
1.0
|
CG
|
B:MET13
|
4.4
|
43.5
|
1.0
|
CE
|
B:MET13
|
4.5
|
43.0
|
1.0
|
O1B
|
B:TTP300
|
4.6
|
38.0
|
1.0
|
CE1
|
B:PHE14
|
4.7
|
43.1
|
1.0
|
C5'
|
B:TTP300
|
4.7
|
29.9
|
1.0
|
SD
|
B:MET13
|
4.7
|
43.5
|
1.0
|
NZ
|
B:LYS17
|
4.8
|
43.0
|
1.0
|
CG
|
B:PHE14
|
4.9
|
43.1
|
1.0
|
|
Magnesium binding site 3 out
of 4 in 2j87
Go back to
Magnesium Binding Sites List in 2j87
Magnesium binding site 3 out
of 4 in the Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg500
b:6.0
occ:1.00
|
O3A
|
C:TTP300
|
2.0
|
32.0
|
1.0
|
O1A
|
C:TTP300
|
2.3
|
30.3
|
1.0
|
O3G
|
C:TTP300
|
2.4
|
31.3
|
1.0
|
PA
|
C:TTP300
|
2.4
|
31.0
|
1.0
|
O5'
|
C:TTP300
|
2.5
|
31.4
|
1.0
|
PB
|
C:TTP300
|
2.9
|
33.4
|
1.0
|
O2B
|
C:TTP300
|
3.0
|
34.0
|
1.0
|
O3B
|
C:TTP300
|
3.2
|
33.1
|
1.0
|
PG
|
C:TTP300
|
3.3
|
33.8
|
1.0
|
CB
|
C:MET13
|
3.6
|
43.4
|
1.0
|
C5'
|
C:TTP300
|
3.8
|
32.9
|
1.0
|
O2A
|
C:TTP300
|
3.9
|
29.9
|
1.0
|
CA
|
C:MET13
|
4.0
|
43.3
|
1.0
|
N
|
C:PHE14
|
4.0
|
43.2
|
1.0
|
O2G
|
C:TTP300
|
4.1
|
33.1
|
1.0
|
CG
|
C:MET13
|
4.2
|
43.4
|
1.0
|
CE
|
C:MET13
|
4.3
|
43.2
|
1.0
|
O1B
|
C:TTP300
|
4.3
|
32.8
|
1.0
|
SD
|
C:MET13
|
4.3
|
43.6
|
1.0
|
O1G
|
C:TTP300
|
4.5
|
35.2
|
1.0
|
NZ
|
C:LYS17
|
4.6
|
43.0
|
1.0
|
C
|
C:MET13
|
4.6
|
43.3
|
1.0
|
C3'
|
C:TTP300
|
4.8
|
36.9
|
1.0
|
C4'
|
C:TTP300
|
4.8
|
34.8
|
1.0
|
CD1
|
C:PHE14
|
5.0
|
42.8
|
1.0
|
|
Magnesium binding site 4 out
of 4 in 2j87
Go back to
Magnesium Binding Sites List in 2j87
Magnesium binding site 4 out
of 4 in the Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg500
b:21.6
occ:1.00
|
O3B
|
D:TTP300
|
1.9
|
39.5
|
1.0
|
O3A
|
D:TTP300
|
2.2
|
39.5
|
1.0
|
O1A
|
D:TTP300
|
2.6
|
37.8
|
1.0
|
PB
|
D:TTP300
|
2.6
|
40.5
|
1.0
|
PA
|
D:TTP300
|
2.8
|
37.4
|
1.0
|
O5'
|
D:TTP300
|
3.2
|
38.9
|
1.0
|
PG
|
D:TTP300
|
3.3
|
40.0
|
1.0
|
O2B
|
D:TTP300
|
3.4
|
41.9
|
1.0
|
CB
|
D:MET13
|
3.7
|
43.4
|
1.0
|
O1G
|
D:TTP300
|
3.8
|
41.1
|
1.0
|
O3G
|
D:TTP300
|
3.8
|
38.9
|
1.0
|
N
|
D:PHE14
|
3.8
|
43.2
|
1.0
|
O1B
|
D:TTP300
|
4.0
|
41.2
|
1.0
|
O2A
|
D:TTP300
|
4.2
|
38.1
|
1.0
|
CA
|
D:MET13
|
4.2
|
43.3
|
1.0
|
CE
|
D:MET13
|
4.3
|
43.1
|
1.0
|
O2G
|
D:TTP300
|
4.4
|
40.7
|
1.0
|
CD1
|
D:PHE14
|
4.4
|
42.8
|
1.0
|
CG
|
D:MET13
|
4.5
|
43.4
|
1.0
|
C
|
D:MET13
|
4.6
|
43.3
|
1.0
|
SD
|
D:MET13
|
4.6
|
43.3
|
1.0
|
C5'
|
D:TTP300
|
4.6
|
42.3
|
1.0
|
CE1
|
D:PHE14
|
4.6
|
43.0
|
1.0
|
CA
|
D:PHE14
|
4.8
|
43.3
|
1.0
|
|
Reference:
K.El Omari,
N.Solaroli,
A.Karlsson,
J.Balzarini,
D.K.Stammers.
Structure of Vaccinia Virus Thymidine Kinase in Complex with Dttp: Insights For Drug Design. Bmc Struct.Biol. V. 6 22 2006.
ISSN: ISSN 1472-6807
PubMed: 17062140
DOI: 10.1186/1472-6807-6-22
Page generated: Wed Aug 14 00:39:21 2024
|